Pulse Biosciences, Inc (PLSE) vs Stevanato Group S.p.A. (STVN)
- Pulse Biosciences, Inc PLSE 44.27 −2.90%
- Stevanato Group S.p.A. STVN 18.90 −1.82%
Pulse Biosciences, Inc and Stevanato Group S.p.A. are both Medical Instruments & Supplies companies. Stevanato Group S.p.A. is the larger, with a market value of $5.3B against $3.3B — 1.6× the size. Pulse Biosciences, Inc has negative trailing earnings, so its P/E is not meaningful; Stevanato Group S.p.A. trades at 33.8×. Stevanato Group S.p.A. grew revenue faster over the last twelve months: 14.3% against −23.3%. Stevanato Group S.p.A. has the higher net margin (11.0% vs −6,755.8%) and the higher return on invested capital (6.56% vs 0.00%). Across the 18 metrics below, Stevanato Group S.p.A. leads on 15 and Pulse Biosciences, Inc on 3.
Valuation
Profitability
| Metric | PLSE | STVN | Medical Instruments & Supplies median |
|---|---|---|---|
| Gross margin | 0.25% | 29.13% | 54.29% |
| Operating margin | (7,007.76%) | 16.29% | 1.07% |
| Net margin | (6,755.78%) | 10.95% | (1.61%) |
| Free cash flow margin | (5,180.42%) | (2.43%) | 1.08% |
| Return on equity | (78.49%) | 9.21% | (1.32%) |
| Return on assets | (67.90%) | 5.46% | 0.00% |
| Return on invested capital | 0.00% | 6.56% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack